Global API(Active Pharmaceutical Ingredient) Intermediate Market Research Report 2018 Opportunities, Size, Cost Structure, Service Provider, Segmentation, Shares, Forecast to 2024

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Aug-2018   |    Format :PDF   |    Number of Pages : 99
This report researches the worldwide API(Active Pharmaceutical Ingredient) Intermediate market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global API(Active Pharmaceutical Ingredient) Intermediate breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Global API(Active Pharmaceutical Ingredient) Intermediate market size will increase to  Million US$ by 2025, from  Million US$ in 2017, at a CAGR of  during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for API(Active Pharmaceutical Ingredient) Intermediate.

This report focuses on the top manufacturers' API(Active Pharmaceutical Ingredient) Intermediate capacity, production, value, price and market share of API(Active Pharmaceutical Ingredient) Intermediate in global market. The following manufacturers are covered in this report:
    Jigs Chemical
    Sanofi Winthrop Industrie S.A.
    Shandong Jiulong Fine Chemical Co., Ltd.
    Hipharma Limited
    AMPAC Fine Chemicals
    BASF
    Cambrex Corporation
    A R Life Sciences Pvt. Ltd.
    Dragon Hwa ChemPharm. Co., Ltd.
    Ami Life Sciences Pvt. Ltd.

API(Active Pharmaceutical Ingredient) Intermediate Breakdown Data by Type
    By Product
        Biotech Intermediates
        Chemical Intermediates
    By Type of Intermediate
        Patent Intermediates
        Non-patent Intermediates
API(Active Pharmaceutical Ingredient) Intermediate Breakdown Data by Application
    Oncology
    Diabetes
    Endocrinology
    Cardiovascular Disease
    CNS & Neurological Disorders

API(Active Pharmaceutical Ingredient) Intermediate Production Breakdown Data by Region
    United States
    Europe
    China
    Japan
    Other Regions

API(Active Pharmaceutical Ingredient) Intermediate Consumption Breakdown Data by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Rest of Europe
    Central & South America
        Brazil
        Rest of South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa
        Rest of Middle East & Africa

The study objectives are:
    To analyze and research the global API(Active Pharmaceutical Ingredient) Intermediate capacity, production, value, consumption, status and forecast;
    To focus on the key API(Active Pharmaceutical Ingredient) Intermediate manufacturers and study the capacity, production, value, market share and development plans in next few years.
    To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
    To define, describe and forecast the market by type, application and region.
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of API(Active Pharmaceutical Ingredient) Intermediate :
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global API(Active Pharmaceutical Ingredient) Intermediate Market Research Report 2018-2025, by Manufacturers, Regions, Types and Applications
1 Study Coverage
    1.1 API(Active Pharmaceutical Ingredient) Intermediate Product
    1.2 Key Market Segments in This Study
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global API(Active Pharmaceutical Ingredient) Intermediate Market Size Growth Rate by Type
        1.4.2 Biotech Intermediates
        1.4.3 Chemical Intermediates
    1.5 Market by Application
        1.5.1 Global API(Active Pharmaceutical Ingredient) Intermediate Market Size Growth Rate by Application
        1.5.2 Oncology
        1.5.3 Diabetes
        1.5.4 Endocrinology
        1.5.5 Cardiovascular Disease
        1.5.6 CNS & Neurological Disorders
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Production
        2.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue 2013-2025
        2.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Production 2013-2025
        2.1.3 Global API(Active Pharmaceutical Ingredient) Intermediate Capacity 2013-2025
        2.1.4 Global API(Active Pharmaceutical Ingredient) Intermediate Marketing Pricing and Trends
    2.2 API(Active Pharmaceutical Ingredient) Intermediate Growth Rate (CAGR) 2018-2025
    2.3 Analysis of Competitive Landscape
        2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        2.3.2 Key API(Active Pharmaceutical Ingredient) Intermediate Manufacturers
    2.4 Market Drivers, Trends and Issues
    2.5 Macroscopic Indicator
        2.5.1 GDP for Major Regions
        2.5.2 Price of Raw Materials in Dollars: Evolution

3 Market Size by Manufacturers
    3.1 API(Active Pharmaceutical Ingredient) Intermediate Production by Manufacturers
        3.1.1 API(Active Pharmaceutical Ingredient) Intermediate Production by Manufacturers
        3.1.2 API(Active Pharmaceutical Ingredient) Intermediate Production Market Share by Manufacturers
    3.2 API(Active Pharmaceutical Ingredient) Intermediate Revenue by Manufacturers
        3.2.1 API(Active Pharmaceutical Ingredient) Intermediate Revenue by Manufacturers (2013-2018)
        3.2.2 API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Manufacturers (2013-2018)
    3.3 API(Active Pharmaceutical Ingredient) Intermediate Price by Manufacturers
    3.4 Mergers & Acquisitions, Expansion Plans

4 API(Active Pharmaceutical Ingredient) Intermediate Production by Regions
    4.1 Global API(Active Pharmaceutical Ingredient) Intermediate Production by Regions
        4.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share by Regions
        4.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Regions
    4.2 United States
        4.2.1 United States API(Active Pharmaceutical Ingredient) Intermediate Production
        4.2.2 United States API(Active Pharmaceutical Ingredient) Intermediate Revenue
        4.2.3 Key Players in United States
        4.2.4 United States API(Active Pharmaceutical Ingredient) Intermediate Import & Export
    4.3 Europe
        4.3.1 Europe API(Active Pharmaceutical Ingredient) Intermediate Production
        4.3.2 Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue
        4.3.3 Key Players in Europe
        4.3.4 Europe API(Active Pharmaceutical Ingredient) Intermediate Import & Export
    4.4 China
        4.4.1 China API(Active Pharmaceutical Ingredient) Intermediate Production
        4.4.2 China API(Active Pharmaceutical Ingredient) Intermediate Revenue
        4.4.3 Key Players in China
        4.4.4 China API(Active Pharmaceutical Ingredient) Intermediate Import & Export
    4.5 Japan
        4.5.1 Japan API(Active Pharmaceutical Ingredient) Intermediate Production
        4.5.2 Japan API(Active Pharmaceutical Ingredient) Intermediate Revenue
        4.5.3 Key Players in Japan
        4.5.4 Japan API(Active Pharmaceutical Ingredient) Intermediate Import & Export
    4.6 Other Regions
        4.6.1 South Korea
        4.6.2 India
        4.6.3 Southeast Asia

5 API(Active Pharmaceutical Ingredient) Intermediate Consumption by Regions
    5.1 Global API(Active Pharmaceutical Ingredient) Intermediate Consumption by Regions
        5.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Consumption by Regions
        5.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Regions
    5.2 North America
        5.2.1 North America API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application
        5.2.2 North America API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries
        5.2.3 United States
        5.2.4 Canada
        5.2.5 Mexico
    5.3 Europe
        5.3.1 Europe API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application
        5.3.2 Europe API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries
        5.3.3 Germany
        5.3.4 France
        5.3.5 UK
        5.3.6 Italy
        5.3.7 Russia
    5.4 Asia Pacific
        5.4.1 Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application
        5.4.2 Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries
        5.4.3 China
        5.4.4 Japan
        5.4.5 South Korea
        5.4.6 India
        5.4.7 Australia
        5.4.8 Indonesia
        5.4.9 Thailand
        5.4.10 Malaysia
        5.4.11 Philippines
        5.4.12 Vietnam
    5.5 Central & South America
        5.5.1 Central & South America API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application
        5.5.2 Central & South America API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries
        5.5.3 Brazil
    5.6 Middle East and Africa
        5.6.1 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application
        5.6.2 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries
        5.6.3 Turkey
        5.6.4 GCC Countries
        5.6.5 Egypt
        5.6.6 South Africa

6 Market Size by Type
    6.1 Global API(Active Pharmaceutical Ingredient) Intermediate Breakdown Dada by Type
    6.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue by Type
    6.3 API(Active Pharmaceutical Ingredient) Intermediate Price by Type

7 Market Size by Application
    7.1 Overview
    7.2 Global API(Active Pharmaceutical Ingredient) Intermediate Breakdown Dada by Application
        7.2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application
        7.2.2 Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Application (2013-2018)

8 Manufacturers Profiles
    8.1 Jigs Chemical
        8.1.1 Jigs Chemical Company Details
        8.1.2 Company Description
        8.1.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate
        8.1.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description
        8.1.5 SWOT Analysis
    8.2 Sanofi Winthrop Industrie S.A.
        8.2.1 Sanofi Winthrop Industrie S.A. Company Details
        8.2.2 Company Description
        8.2.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate
        8.2.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description
        8.2.5 SWOT Analysis
    8.3 Shandong Jiulong Fine Chemical Co., Ltd.
        8.3.1 Shandong Jiulong Fine Chemical Co., Ltd. Company Details
        8.3.2 Company Description
        8.3.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate
        8.3.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description
        8.3.5 SWOT Analysis
    8.4 Hipharma Limited
        8.4.1 Hipharma Limited Company Details
        8.4.2 Company Description
        8.4.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate
        8.4.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description
        8.4.5 SWOT Analysis
    8.5 AMPAC Fine Chemicals
        8.5.1 AMPAC Fine Chemicals Company Details
        8.5.2 Company Description
        8.5.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate
        8.5.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description
        8.5.5 SWOT Analysis
    8.6 BASF
        8.6.1 BASF Company Details
        8.6.2 Company Description
        8.6.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate
        8.6.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description
        8.6.5 SWOT Analysis
    8.7 Cambrex Corporation
        8.7.1 Cambrex Corporation Company Details
        8.7.2 Company Description
        8.7.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate
        8.7.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description
        8.7.5 SWOT Analysis
    8.8 A R Life Sciences Pvt. Ltd.
        8.8.1 A R Life Sciences Pvt. Ltd. Company Details
        8.8.2 Company Description
        8.8.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate
        8.8.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description
        8.8.5 SWOT Analysis
    8.9 Dragon Hwa ChemPharm. Co., Ltd.
        8.9.1 Dragon Hwa ChemPharm. Co., Ltd. Company Details
        8.9.2 Company Description
        8.9.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate
        8.9.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description
        8.9.5 SWOT Analysis
    8.10 Ami Life Sciences Pvt. Ltd.
        8.10.1 Ami Life Sciences Pvt. Ltd. Company Details
        8.10.2 Company Description
        8.10.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate
        8.10.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description
        8.10.5 SWOT Analysis

9 Production Forecasts
    9.1 API(Active Pharmaceutical Ingredient) Intermediate Production and Revenue Forecast
        9.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Production Forecast 2018-2025
        9.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast 2018-2025
    9.2 API(Active Pharmaceutical Ingredient) Intermediate Production and Revenue Forecast by Regions
        9.2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Regions
        9.2.2 Global API(Active Pharmaceutical Ingredient) Intermediate Production Forecast by Regions
    9.3 API(Active Pharmaceutical Ingredient) Intermediate Key Producers Forecast
        9.3.1 United States
        9.3.2 Europe
        9.3.3 China
        9.3.4 Japan
    9.4 Forecast by Type
        9.4.1 Global API(Active Pharmaceutical Ingredient) Intermediate Production Forecast by Type
        9.4.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Type

10 Consumption Forecast
    10.1 Consumption Forecast by Application
    10.2 API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Regions
    10.3 North America Market Consumption Forecast
        10.3.1 North America API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Countries 2018-2025
        10.3.2 United States
        10.3.3 Canada
        10.3.4 Mexico
    10.4 Europe Market Consumption Forecast
        10.4.1 Europe API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Countries 2018-2025
        10.4.2 Germany
        10.4.3 France
        10.4.4 UK
        10.4.5 Italy
        10.4.6 Russia
    10.5 Asia Pacific Market Consumption Forecast
        10.5.1 Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Countries 2018-2025
        10.5.2 China
        10.5.3 Japan
        10.5.4 Korea
        10.5.5 India
        10.5.6 Australia
        10.5.7 Indonesia
        10.5.8 Thailand
        10.5.9 Malaysia
        10.5.10 Philippines
        10.5.11 Vietnam
    10.6 Central & South America Market Consumption Forecast
        10.6.1 Central & South America API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Country 2018-2025
        10.6.2 Brazil
    10.7 Middle East and Africa Market Consumption Forecast
        10.7.1 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Countries 2018-2025
        10.7.2 Middle East and Africa
        10.7.3 Turkey
        10.7.4 GCC Countries
        10.7.5 Egypt
        10.7.6 South Africa

11 Upstream, Industry Chain and Downstream Customers Analysis
    11.1 Analysis of API(Active Pharmaceutical Ingredient) Intermediate Upstream Market
        11.1.1 API(Active Pharmaceutical Ingredient) Intermediate Key Raw Material
        11.1.2 Typical Suppliers of Key API(Active Pharmaceutical Ingredient) Intermediate Raw Material
        11.1.3 API(Active Pharmaceutical Ingredient) Intermediate Raw Material Market Concentration Rate
    11.2 API(Active Pharmaceutical Ingredient) Intermediate Industry Chain Analysis
    11.3 Marketing & Distribution
    11.4 API(Active Pharmaceutical Ingredient) Intermediate Distributors
    11.5 API(Active Pharmaceutical Ingredient) Intermediate Customers

12 Opportunities & Challenges, Threat and Affecting Factors
    12.1 Market Opportunities
    12.2 Market Challenges
    12.3 Porter's Five Forces Analysis
    12.4 Affecting Factors

13 Key Findings

14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer



List of Tables and Figures

    Figure API(Active Pharmaceutical Ingredient) Intermediate Product Picture
    Table API(Active Pharmaceutical Ingredient) Intermediate Key Market Segments in This Study
    Table Key Manufacturers API(Active Pharmaceutical Ingredient) Intermediate Covered in This Study
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Market Size Growth Rate by Type 2018-2025 (K MT) & (Million US$)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share 2013-2025
    Figure Biotech Intermediates Product Picture
    Table Major Manufacturers of Biotech Intermediates
    Figure Chemical Intermediates Product Picture
    Table Major Manufacturers of Chemical Intermediates
   Table Global API(Active Pharmaceutical Ingredient) Intermediate Market Size Growth Rate by Application 2018-2025 (K MT)
    Figure Oncology
    Figure Diabetes
    Figure Endocrinology
    Figure Cardiovascular Disease
    Figure CNS & Neurological Disorders
    Figure API(Active Pharmaceutical Ingredient) Intermediate Report Years Considered
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue 2013-2025 (Million US$)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production 2013-2025 (K MT)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Capacity 2013-2025 (K MT)
    Table Key Manufacturers API(Active Pharmaceutical Ingredient) Intermediate Capacity (K MT)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Price 2013-2025 (USD/MT)
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Market Size Growth Rate by Regions 2018-2025(K MT) & (Million US$)
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table API(Active Pharmaceutical Ingredient) Intermediate Manufacturing Base Distribution and Headquarters
    Table Manufacturers API(Active Pharmaceutical Ingredient) Intermediate Product Offered
    Table Date of Manufacturers Enter into API(Active Pharmaceutical Ingredient) Intermediate Market
    Figure GDP for Major Regions in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Figure Price of raw materials in dollars: Evolution
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Production by Manufacturers (2013-2018) (K MT)
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Production Share by Manufacturers (2013-2018)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Share by Manufacturers in 2017
    Table API(Active Pharmaceutical Ingredient) Intermediate Revenue by Manufacturers (2013-2018) (Million US$)
    Table API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Manufacturers (2013-2018)
    Figure API(Active Pharmaceutical Ingredient) Intermediate Value Share by Manufacturers in 2017
    Table API(Active Pharmaceutical Ingredient) Intermediate Price by Manufacturers 2013-2018 (USD/MT)
    Table Mergers & Acquisitions, Expansion Plans
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Production by Regions 2013-2018 (K MT)
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share by Regions 2013-2018
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share by Regions 2013-2018
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share by Regions in 2017
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue by Regions 2013-2018 (Million US$)
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Regions 2013-2018
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Regions 2013-2018
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Regions in 2017
    Figure United States API(Active Pharmaceutical Ingredient) Intermediate Production and Growth Rate 2013-2018 (K MT)
    Figure United States API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate 2013-2018 (Million US$)
    Table United States API(Active Pharmaceutical Ingredient) Intermediate Import & Export
    Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Production and Growth Rate 2013-2018 (K MT)
    Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate 2013-2018 (Million US$)
    Table Europe API(Active Pharmaceutical Ingredient) Intermediate Import & Export
    Figure China API(Active Pharmaceutical Ingredient) Intermediate Production and Growth Rate 2013-2018 (K MT)
    Figure China API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate 2013-2018 (Million US$)
    Table China API(Active Pharmaceutical Ingredient) Intermediate Import & Export
    Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Production and Growth Rate 2013-2018 (K MT)
    Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate 2013-2018 (Million US$)
    Table Japan API(Active Pharmaceutical Ingredient) Intermediate Import & Export
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption by Regions 2013-2018 (K MT)
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Regions 2013-2018
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Regions 2013-2018
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Regions in 2017
    Figure North America API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Table North America API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application (2013-2018) (K MT)
    Figure 2017 North America API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Application
    Table North America API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries (2013-2018) (K MT)
    Figure 2017 North America API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Countries
    Figure United States API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure Canada API(Active Pharmaceutical Ingredient) Intermediate Consumption (K MT) and Growth Rate (2013-2018)
    Figure Mexico API(Active Pharmaceutical Ingredient) Intermediate Consumption (K MT) and Growth Rate (2013-2018)
    Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Table Europe API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application (2013-2018) (K MT)
    Figure 2017 Europe API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Application
    Table Europe API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries (2013-2018) (K MT)
    Figure 2017 Europe API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Countries
    Figure Germany API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure France API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure UK API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure Italy API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure Russia API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (K MT)
    Table Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application (2013-2018) (K MT)
    Table Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Application (2013-2018) (K MT)
    Table Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries (2013-2018) (K MT)
    Table Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Countries (2013-2018) (K MT)
    Figure China API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure Korea API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure India API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure Australia API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure Indonesia API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure Thailand API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure Malaysia API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure Philippines API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure Vietnam API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure Central & South America API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (K MT)
    Table Central & South America API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application (2013-2018) (K MT)
    Figure 2017 Central & South America API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Application
    Table Central & South America API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries (2013-2018) (K MT)
    Figure Central & South America API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Countries
    Figure Brazil API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (K MT)
    Table Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application (2013-2018) (K MT)
    Figure 2017 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Application
    Table Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries (2013-2018) (K MT)
    Figure Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Countries
    Figure Turkey API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure GCC Countries API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure Egypt API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Figure South Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2013-2018) (K MT)
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Production by Type (2013-2018) (K MT)
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Production Share by Type (2013-2018)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share by Type (2013-2018)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share by Type in 2017
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue by Type (2013-2018) (Million US$)
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Type (2013-2018)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Type (2013-2018)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Type in 2017
    Table API(Active Pharmaceutical Ingredient) Intermediate Price by Type 2013-2018 (USD/MT)
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application (2013-2025) (K MT)
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application (2013-2018) (K MT)
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Share by Application (2013-2018)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Application (2013-2018)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Value (Consumption) Market Share by Application (2013-2018)
    Table Jigs Chemical Company Details
    Table Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
    Figure Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2013-2018)
    Figure Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market
    Table Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis
    Table Sanofi Winthrop Industrie S.A. Company Details
    Table Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
    Figure Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2013-2018)
    Figure Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market
    Table Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis
    Table Shandong Jiulong Fine Chemical Co., Ltd. Company Details
    Table Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
    Figure Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2013-2018)
    Figure Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market
    Table Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis
    Table Hipharma Limited Company Details
    Table Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
    Figure Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2013-2018)
    Figure Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market
    Table Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis
    Table AMPAC Fine Chemicals Company Details
    Table AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
    Figure AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2013-2018)
    Figure AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market
    Table AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis
    Table BASF Company Details
    Table BASF API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
    Figure BASF API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2013-2018)
    Figure BASF API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market
    Table BASF API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis
    Table Cambrex Corporation Company Details
    Table Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
    Figure Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2013-2018)
    Figure Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market
    Table Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis
    Table A R Life Sciences Pvt. Ltd. Company Details
    Table A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
    Figure A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2013-2018)
    Figure A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market
    Table A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis
    Table Dragon Hwa ChemPharm. Co., Ltd. Company Details
    Table Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
    Figure Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2013-2018)
    Figure Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market
    Table Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis
    Table Ami Life Sciences Pvt. Ltd. Company Details
    Table Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
    Figure Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2013-2018)
    Figure Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market
    Table Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Forecast 2018-2025 (K MT)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast 2018-2025 (Million US$)
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast 2018-2025 (Million US$)
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Regions 2018-2025 (Million US$)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Regions 2018-2025 (Million US$)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share Forecast by Regions 2018-2025
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Production Forecast by Regions 2018-2025 (K MT)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Forecast by Regions 2018-2025 (K MT)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share Forecast by Regions 2018-2025
    Figure United States API(Active Pharmaceutical Ingredient) Intermediate Production Forecast 2018-2025 (K MT)
    Figure United States API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast 2018-2025 (Million US$)
    Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Production Forecast 2018-2025 (K MT)
    Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast 2018-2025 (Million US$)
    Figure China API(Active Pharmaceutical Ingredient) Intermediate Production Forecast 2018-2025 (K MT)
    Figure China API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast 2018-2025 (Million US$)
    Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Production Forecast 2018-2025 (K MT)
    Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast 2018-2025 (Million US$)
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Production Forecast by Type 2018-2025 (K MT)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Forecast by Type 2018-2025 (K MT)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share Forecast by Type 2018-2025
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Type 2018-2025 (Million US$)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Type 2018-2025 (Million US$)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share Forecast by Type 2018-2025
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Application 2018-2025 (K MT)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Application 2018-2025 (K MT)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share Forecast by Application 2018-2025
    Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Regions 2018-2025 (K MT)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Regions 2018-2025 (K MT)
    Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share Forecast by Regions 2018-2025
    Table North America API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Regions 2018-2025 (K MT)
    Figure United States API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure Canada API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure MexicoAPI(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Table Europe API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Regions 2018-2025 (K MT)
    Figure Germany API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure France API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure UK API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure Italy API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure Russia API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Table Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Regions 2018-2025 (K MT)
    Figure China API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure Korea API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure India API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure Australia API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure Indonesia API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure Thailand API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure Malaysia API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure Philippines API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure Vietnam API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Table Central & South America API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Regions 2018-2025 (K MT)
    Figure Brazil API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Table Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Regions 2018-2025 (K MT)
    Figure Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure Turkey API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure GCC Countries API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure Egypt API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Figure South Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2018-2025 (K MT)
    Table API(Active Pharmaceutical Ingredient) Intermediate Key Raw Material
    Table Typical Suppliers of Key API(Active Pharmaceutical Ingredient) Intermediate Raw Material
    Figure API(Active Pharmaceutical Ingredient) Intermediate Industry Chain
    Table Distributors/Traders List
    Table API(Active Pharmaceutical Ingredient) Intermediate Customers List
    Table Porter’s Five Forces Analysis
    Figure Price Trend of Crude Oil (USD/BBL)
    Figure Price Trend of Brent Crude Oil (USD/BBL)
    Figure Price Trend of Natural Gas (MMBtu)
    Figure Price Trend of Coal (USD/MT)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

25-Feb-2019 | Medical Devices

Launch Of Symjepi Epinephrine Syringe To Boost The Syringe Market Growth In US

A rising burden of chronic diseases has been observed all across the world, which, in turn, has elevated the usage of syringes. Overall, the global syringe market is anticipated to observe vigorous ...

25-Feb-2019 | Electrical & Electronic Device

Launch Of Xiaomi Set-Top Box To Power The Global 4K Set-Top Box Market

While smart TVs are turning out to be much more widespread these days, a number of consumers still choose to opt for normal TVs and then employ smart streaming set top box with them. Popular choice ...

13-Feb-2019 | Software

Bioinspired Artificial Bug Eye Creation Is A Baton For Global Autonomous Car Market

After looking at the different eye lens structures of the animals and humans, the researchers have decided on creating a sharp image using its design. The compound eyes of the bugs are currently be ...

13-Feb-2019 | Consumer Goods & Retailing

Cafe X’s $12 Million “Seed-1” Round To Boost The Global Coffee Market

Cafe X, a company engaged in building robot baristas, is about to raise a $12 Million “Seed-1” round. Recently, Crunchbase News broke the story when it came across regulatory f ...

05-Feb-2019 | Chemicals & Materials

Clinically Produced Cells Change The Horizon Of Global Bone Cement And Glue Market

The group of researchers from the New York Stem Cell Foundation Research Institute published an article in Stem Cell Research and Therapy where the details regarding the clinical ...